Optimind Pharma Corp. (CSE:OMND)

Market Cap	1.10M
Revenue (ttm)	111.33K
Net Income (ttm)	-895.12K
Shares Out	109.79M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	14,088
Open	n/a
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.0100
Beta	0.99
RSI	99.79
Earnings Date	Jun 27, 2025

About Optimind Pharma

Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clinic that provides medical cannabis and other alternative treatments for various medical ailments, including ketamine-enhanced psychotherapy. The company is headquartered in Toronto, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: David Goodman
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OMND

Financial Performance

In 2023, Optimind Pharma's revenue was 122,959, a decrease of -27.72% compared to the previous year's 170,113. Losses were -1.40 million, -54.60% less than in 2022.